| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Nov 7, 2025 | Vir Biotechnology, Inc. | EVP, General Counsel, Corp Sec | Sell | 45.0 | -2,385 | -2.96% | ✓ | $12.3K |
| Nov 3, 2025 | Nov 4, 2025 | Vir Biotechnology, Inc. | EVP and General Counsel | Sell | 47.5 | -1,365 | -1.67% | ✗ | $8K |
| Feb 26, 2025 | Feb 27, 2025 | Vir Biotechnology, Inc. | EVP and General Counsel | Sell | 28.8 | -7,373 | -8.49% | ✓ | $67.4K |
| Feb 22, 2025 | Feb 25, 2025 | Vir Biotechnology, Inc. | EVP and General Counsel | Sell | 91.3 | +29,860 | 52.41% | ✗ | $48.6K |
| Dec 2, 2024 | Dec 4, 2024 | Vir Biotechnology, Inc. | EVP and General Counsel | Sell | 52.5 | -76 | -0.13% | ✗ | $624.7 |
| Nov 6, 2024 | Nov 7, 2024 | Vir Biotechnology, Inc. | EVP and General Counsel | Sell | 36.3 | -4,397 | -7.16% | ✓ | $44.5K |
| Nov 1, 2024 | Nov 5, 2024 | Vir Biotechnology, Inc. | EVP and General Counsel | Sell | 36.3 | -3,750 | -5.76% | ✓ | $32.3K |